Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP.

NCT01983657 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Alveolar Proteinosis

Interventions

DRUG: rhGM-CSF
PROCEDURE: Whole Lung Lavage(WLL)

Sponsor

Shanghai Pulmonary Hospital, Shanghai, China